Spin-off - LanzaTech Global, Inc.

Add to your watchlist
Back to List of Spin Offs

Form Type: 8-K

Filing Date: 2025-03-04

Corporate Action: Spin-off

Type: Update

Accession Number: 000162828025009942

Filing Summary: On March 4, 2025, LanzaTech Global, Inc. issued a press release detailing its strategic actions to transition from an innovation hub to a profitable enterprise. This includes the planned spin-off of LanzaX, as announced on January 21, 2025, and the exploration of partnership opportunities related to its nutritional protein capabilities, termed LanzaTech Nutritional Protein (LNP). The company is also undertaking initiatives to improve global scalability and cost-effectiveness of its operations. Additionally, LanzaTech rescheduled its earnings release and conference call to March 31, 2025, to align financial disclosures more closely with its Annual Report filing.

Additional details:

Date Of Report: 2025-03-04

Previously Announced Earnings Release Date: 2025-03-31

Form Type: 8-K

Filing Date: 2025-01-22

Corporate Action: Spin-off

Type: New

Accession Number: 000162828025002081

Filing Summary: On January 21, 2025, LanzaTech Global, Inc. reported the resignation of Chief Financial Officer Geoff Trukenbrod, with Justin D. Pugh appointed as interim CFO effective the same day. Pugh, a Senior Managing Director at FTI Consulting, will continue his employment with FTI and will not receive compensation from LanzaTech. Additionally, the company announced its intention to form LanzaX, a new business unit dedicated to its synthetic biology platform, intending to spin it out from its core biorefining business. This was also communicated in a press release issued on the same date.

Additional details:

Item 5 02: Geoff Trukenbrod resigned as CFO, and Justin D. Pugh appointed interim CFO.

Item 8 01: Announcement of planned formation of LanzaX.

New Business Unit: LanzaX, focused on synthetic biology platform.

Effective Date: January 21, 2025

Appointment Of Officer: Justin D. Pugh as interim CFO effective January 21, 2025.

Comments

No comments yet. Be the first to comment!